Influence of Hispanic ethnicity on liver histology and treatment response in HIV/HCV genotype 1 co-infected subjects on pegylated interferon and ribavirin

被引：0
|
作者：
Uriel, AJ
Park, J
Moorehead, L
Camera, D
Lucas, J
Sulkowski, M
Dieterich, DT
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A724 / A724
页数：1
相关论文
共 50 条
  • [1] Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin
    Dahari, Harel
    Markatou, Marianthi
    Zeremski, Marija
    Haller, Ivan
    Ribeiro, Ruy M.
    Licholai, Teresa
    Perelson, Alan S.
    Talal, Andrew H.
    JOURNAL OF HEPATOLOGY, 2007, 47 (01) : 23 - 30
  • [2] Effect of Aging, Glucose Level, and HIV Viral Load on Response to Treatment with Pegylated Interferon Plus Ribavirin in HIV/HCV Co-Infected Women
    Nasta, Paola
    Maida, Ivana
    Cattelan, Anna Maria
    Pontali, Emanuele
    Angeli, Elena
    Giralda, Mariarosaria
    Verucchi, Gabriella
    Caputo, Antonietta
    Iannacone, Claudio
    Puoti, Massimo
    Carosi, Giampiero
    JOURNAL OF WOMENS HEALTH, 2015, 24 (02) : 159 - 164
  • [3] Effects of interferon/ribavirin on bone turnover markers (BTMs) in HIV/HCV co-infected subjects
    Bedimo, R.
    Kang, M.
    Tebas, P.
    Overton, E.
    Hollabaugh, K.
    McComsey, G.
    Bhattacharya, D.
    Evans, C.
    Brown, T.
    Taiwo, B.
    ANTIVIRAL THERAPY, 2014, 19 : A18 - A18
  • [4] Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients
    Marchetti, Giulia
    Nasta, Paola
    Bai, Francesca
    Gatti, Francesca
    Bellistri, Giusi Maria
    Tincati, Camilla
    Borghi, Federica
    Carosi, Giampiero
    Puoti, Massimo
    Monforte, Antonella d'Arminio
    PLOS ONE, 2012, 7 (02):
  • [5] Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients
    Merchante, Nicolas
    de los Santos-Gil, Ignacio
    Merino, Dolores
    Gonzalez-Serrano, Mercedes
    Mira, Jose A.
    Sanz-Sanz, Jesus
    Fernandez-Fuertes, Elisa
    Ruiz-Morales, Josefa
    del Valle, Jose
    Macias, Juan
    Moro, Antonio
    Pineda, Juan A.
    JOURNAL OF HEPATOLOGY, 2009, 50 (04) : 684 - 692
  • [6] Treatment of chronic Hepatitis C with pegylated interferon and ribavirin in HIV co-infected patients.
    Hopkins, S
    Hennessy, M
    Lyons, F
    Mulachy, F
    Bergin, C
    HEPATOLOGY, 2002, 36 (04) : 231A - 231A
  • [7] Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin
    Sjogren, Maria H.
    Sjogren, Robert, Jr.
    Lyons, Michael F.
    Ryan, Michael
    Santoro, John
    Smith, Coleman
    Reddy, K. Rajender
    Bonkovsky, Herbert
    Huntley, Brooke
    Faris-Young, Sima
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (06) : 1540 - 1547
  • [8] Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin
    Maria H. Sjogren
    Robert Sjogren
    Michael F. Lyons
    Michael Ryan
    John Santoro
    Coleman Smith
    K. Rajender Reddy
    Herbert Bonkovsky
    Brooke Huntley
    Sima Faris-Young
    Digestive Diseases and Sciences, 2007, 52 : 1540 - 1547
  • [9] Presence of multiple HCV genotypes and response to interferon-ribavirin therapy HIV/HCV co-infected patients
    Bonacini, M
    Bzowej, N
    Phuong, Y
    HEPATOLOGY, 2004, 40 (04) : 409A - 409A
  • [10] Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4
    Rivero-Juarez, Antonio
    Camacho Espejo, Angela
    Perez-Camacho, Ines
    Neukam, Karin
    Caruz, Antonio
    Antonio Mira, Jose
    Mesa, Pilar
    Garcia-Lazaro, Milagros
    Torre-Cisneros, Julian
    Antonio Pineda, Juan
    Rivero, Antonio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (01) : 202 - 205
12345